High-brightness anterograde transneuronal HSV1 H129 tracer modified using a Trojan horse-like strategy.
Animals
Axonal Transport
/ physiology
Brain
/ cytology
Cell Line
Cell Nucleus
/ virology
Defective Viruses
/ genetics
Dependovirus
/ genetics
Genes, Reporter
Genes, Synthetic
Green Fluorescent Proteins
/ analysis
Helper Viruses
/ genetics
Herpesvirus 1, Human
/ genetics
Male
Mice
Mice, Inbred C57BL
Neural Pathways
/ ultrastructure
Neuroanatomical Tract-Tracing Techniques
/ methods
Neuronal Tract-Tracers
/ analysis
Neurons
/ ultrastructure
Reassortant Viruses
/ genetics
Viral Replicase Complex Proteins
/ genetics
Virus Replication
Adeno-associated virus
Anterograde tracer
H129
Herpes simplex virus
High-brightness
Neural circuit tracing
Trojan horse-like strategy
Journal
Molecular brain
ISSN: 1756-6606
Titre abrégé: Mol Brain
Pays: England
ID NLM: 101468876
Informations de publication
Date de publication:
13 01 2020
13 01 2020
Historique:
received:
17
08
2019
accepted:
05
01
2020
entrez:
15
1
2020
pubmed:
15
1
2020
medline:
13
2
2021
Statut:
epublish
Résumé
Neurotropic viral transsynaptic tracing is an increasingly powerful technique for dissecting the structure and function of neural circuits. Herpes simplex virus type 1 strain H129 has been widely used as an anterograde tracer. However, HSV tracers still have several shortcomings, including high toxicity, low sensitivity and non-specific retrograde labeling. Here, we aimed to construct high-brightness HSV anterograde tracers by increasing the expression of exogenous genes carried by H129 viruses. Using a Trojan horse-like strategy, a HSV/AAV (adeno-associated virus) chimaera termed H8 was generated to enhance the expression of a fluorescent marker. In vitro and in vivo assays showed that the exogenous gene was efficiently replicated and amplified by the synergism of the HSV vector and introduced AAV replication system. H8 reporting fluorescence was brighter than that of currently available H129 tracers, and H8 could be used for fast and effective anterograde tracing without additional immunostaining. These results indicated that foreign gene expression in HSV tracers could be enhanced by integrating HSV with AAV replication system. This approach may be useful as a general enhanced expression strategy for HSV-based tracing tools or gene delivery vectors.
Identifiants
pubmed: 31931837
doi: 10.1186/s13041-020-0544-2
pii: 10.1186/s13041-020-0544-2
pmc: PMC6958791
doi:
Substances chimiques
Neuronal Tract-Tracers
0
Viral Replicase Complex Proteins
0
enhanced green fluorescent protein
0
Green Fluorescent Proteins
147336-22-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5Références
J Neurosci. 1995 Apr;15(4):2972-84
pubmed: 7536824
Am J Physiol Regul Integr Comp Physiol. 2009 Mar;296(3):R501-11
pubmed: 19109367
Front Neuroanat. 2015 Jul 01;9:80
pubmed: 26190977
Hum Gene Ther. 1999 Oct 10;10(15):2481-94
pubmed: 10543613
Nat Methods. 2007 Jan;4(1):47-9
pubmed: 17179932
Methods Mol Biol. 2014;1144:63-79
pubmed: 24671677
Prog Neurobiol. 2004 Apr;72(6):417-45
pubmed: 15177785
BioDrugs. 2017 Aug;31(4):317-334
pubmed: 28669112
Nature. 2003 Jul 17;424(6946):251
pubmed: 12867952
Curr Protoc Neurosci. 2001 May;Chapter 1:Unit1.5
pubmed: 18428451
Methods Mol Biol. 2015;1254:269-93
pubmed: 25431072
J Chem Neuroanat. 2019 Oct;100:101662
pubmed: 31348990
Hum Gene Ther. 1997 Feb 10;8(3):359-70
pubmed: 9048203
Viruses. 2013 Feb 11;5(2):678-707
pubmed: 23435239
Neurosci Biobehav Rev. 2016 Sep;68:370-386
pubmed: 27235078
Brain Struct Funct. 2015;220(3):1395-420
pubmed: 24585022
Infect Immun. 1983 Apr;40(1):103-12
pubmed: 6299955
J Gen Virol. 2015 Apr;96(Pt 4):840-50
pubmed: 25535322
Gene Ther. 2004 May;11(10):829-37
pubmed: 14985784
Hum Gene Ther. 2009 Aug;20(8):796-806
pubmed: 19569968
Methods Mol Biol. 2015;1254:295-316
pubmed: 25431073
J Comp Neurol. 1982 Nov 1;211(3):295-308
pubmed: 7174895
Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8048-51
pubmed: 1654557
Nat Neurosci. 2016 Feb;19(2):283-9
pubmed: 26727549
Open Virol J. 2010 Jun 18;4:109-22
pubmed: 20811580
Science. 2001 Mar 30;291(5513):2608-13
pubmed: 11283374
Neurosci Bull. 2019 Oct;35(5):909-920
pubmed: 31004271
Curr Opin Neurobiol. 2008 Dec;18(6):617-23
pubmed: 19349161
Cell. 2014 Feb 27;156(5):1096-111
pubmed: 24581503
PLoS Pathog. 2009 Mar;5(3):e1000340
pubmed: 19282980
Microbiol Spectr. 2015 Aug;3(4):null
pubmed: 26350320
Curr Opin Mol Ther. 2001 Oct;3(5):482-90
pubmed: 11699893
Cold Spring Harb Protoc. 2012 Mar 01;2012(3):352-6
pubmed: 22383640
J Neurosci. 2004 Mar 17;24(11):2782-6
pubmed: 15028771
Neuron. 2007 Mar 1;53(5):639-47
pubmed: 17329205
Neuron. 2011 Dec 22;72(6):938-50
pubmed: 22196330
Appl Microbiol Biotechnol. 2018 Feb;102(3):1045-1054
pubmed: 29204900
J Virol. 1981 Oct;40(1):241-7
pubmed: 6270377
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15414-9
pubmed: 21825165
Curr Gene Ther. 2004 Dec;4(4):385-408
pubmed: 15578989
Curr Gene Ther. 2005 Jun;5(3):265-71
pubmed: 15975004